Novartis Self-Medication second-tier management announced by Ciba/Sandoz.
This article was originally published in The Tan Sheet
Executive Summary
NOVARTIS SELF-MEDICATION U.S. "MANAGEMENT TEAM" SELECTED as the pending merger between Ciba-Geigy and Sandoz draws closer, the firms announced June 26. Of the seven VP-level appointments, four are from Sandoz Consumer Pharmaceuticals Corporation and three are from Ciba Self-Medication. All appointed VPs will report directly to Fred Huser, president-designate of Novartis Self-Medication, the companies stated. Huser was chosen to head the combined companies' OTC business in May ("The Tan Sheet" May 13, p. 6).
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning